Table 3.
Mortality in black and white patients diagnosed with lung, liver, pancreatic and esophageal cancer. Based on SEER-Medicare 2000-2005, with follow up through 2008.
| Hazard ratio (HR) of mortality associated with black vs. white race | ||||
|---|---|---|---|---|
|
| ||||
| Modelsŧ | Liver HR (95%CI) | Lung HR (95%CI) | Pancreas HR (95%CI) | Esophagus HR (95%CI) |
| Unadjusted | 1.11 (0.97-1.28) | 1.19 (1.14 - 1.25)ŧŧŧ | 1.23 (1.11-1.36)ŧŧŧ | 1.21 (1.07-1.37)ŧŧŧ |
| Adjusted sequentially for: | ||||
| Patient factors* | 1.04 (0.89-1.22) | 1.09 (1.04-1.14)ŧŧŧ | 1.17 (1.05-1.31)ŧŧŧ | 1.12 (0.98-1.28) |
| Patient factors + tumor factors** | 1.07 (0.92-1.24) | 1.04 (1.00-1.09) | 1.15 (1.03-1.28)ŧŧŧ | 1.08 (0.95-1.23) |
| Patient factors + tumor factors + hospital characteristics*** | 1.10 (0.95-1.27) | 1.05 (1.00-1.10)ŧŧ | 1.15 (1.03-1.30)ŧŧŧ | 1.05 (0.91-1.20) |
| Patient factors + tumor factors + hospital characteristics + surgery**** | 1.01 (0.88-1.17) | 0.98 (0.94-1.02) | 1.06 (0.94-1.19) | 1.02 (0.89-1.17) |
Complete case analysis of 2,567 liver, 42,991 lung, 5,795 pancreas and 3,611 esophageal cancer patients.
p<0.05
p <0.01
Patient factors: age (65-69, 70-74, 75-79, ≥79 years), gender (male, female), comorbid conditions (0, 1, ≥2), marital status (married, single, other), socioeconomic status (median zip code level income).
Tumor factors: SEER stage (local, regional), size (<2.0 cm, 2.0-2.9 cm, 3.0-3.9 cm, 4.0-4.9 cm, ≥5 cm)
Hospital characteristics: operative volume (cancer-specific procedure volume), teaching status (yes, no)
Receipt of cancer directed surgery within 6 months of diagnosis